In the HNSCC cell line Detroit-562, activation of TLR3/NF-κB can upregulate the expression of ICAM-1, IL-6, IL-8, and IL-1β and promote cell migration but decrease cell viability (51). This evidence concerns the gene TLR3 and head and neck squamous cell carcinoma.